Article info

Download PDFPDF
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern

Authors

  • Jean-Baptiste Vulsteke Development and Regeneration, Skeletal Biology Engineering and Research Center, KU Leuven, Leuven, BelgiumRheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Yves Piette Internal Medicine, Ghent University, Ghent, BelgiumRheumatology, Ghent University Hospital, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Carolien Bonroy Diagnostic Sciences, Ghent University, Ghent, BelgiumLaboratory Medicine, Ghent University Hospital, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Patrick Verschueren Development and Regeneration, Skeletal Biology Engineering and Research Center, KU Leuven, Leuven, BelgiumRheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Daniel Blockmans Microbiology, Immunology and Transplantation, Laboratory for Clinical Infectious and Inflammatory Disorders, KU Leuven, Leuven, BelgiumGeneral Internal Medicine, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Steven Vanderschueren Microbiology, Immunology and Transplantation, Laboratory for Clinical Infectious and Inflammatory Disorders, KU Leuven, Leuven, BelgiumGeneral Internal Medicine, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Kristl G Claeys Neurosciences, Laboratory for Muscle Diseases and Neuropathies, KU Leuven, Leuven, BelgiumNeurology, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Petra De Haes Microbiology, Immunology and Transplantation, KU Leuven, Leuven, BelgiumDermatology, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Jan Leo Lenaerts Rheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Wim A Wuyts Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery, KU Leuven, Leuven, BelgiumRespiratory Diseases, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Takashi Matsushita Dermatology, Kanazawa University, Kanazawa, Japan PubMed articlesGoogle scholar articles
  • Vanessa Smith Rheumatology, Ghent University Hospital, Ghent, BelgiumInternal Medicine; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Ellen De Langhe Development and Regeneration, Skeletal Biology Engineering and Research Center, KU Leuven, Leuven, BelgiumRheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Xavier Bossuyt Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, BelgiumLaboratory Medicine, KU Leuven University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xavier Bossuyt, Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Flanders, Belgium; xavier.bossuyt{at}uzleuven.be
View Full Text

Citation

Vulsteke J, Piette Y, Bonroy C, et al
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern

Publication history

  • Received January 26, 2021
  • Accepted January 5, 2022
  • First published January 13, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.